GE HealthCare Trims 2025 Outlook, 1Q Results Increase from Year Earlier

Dow Jones
2025/04/30
 

By Denny Jacob

 

GE HealthCare trimmed its estimates for the year after assuming the impact of tariffs on its outlook.

The maker of magnetic-resonance imaging scanners and other health-care machines now expects adjusted earnings per-share to be in the range of $3.90 to $4.10. It previously guided for adjusted earnings between $4.61 a share and $4.75 a share.

Free cash flow is now expected to be at least $1.2 billion, down from prior guidance calling for at least $1.75 billion.

Chief Executive Peter Arduini said the company is actively driving mitigation actions in regards to the current global trade environment.

The Chicago company logged net income of $564 million, or $1.23 a share, up from $374 million, or 81 cents a share, in the prior-year period.

Stripping out certain one-time items, earnings came in at $1.01 a share. Analysts polled by FactSet expected 91 cents a share.

Revenue rose to $4.78 billion from $4.65 billion. Analysts polled by FactSet expected $4.66 billion.

GE HealthCare said revenue growth was broad-based with growth in each segment, with overall strength in the U.S.

GE HealthCare also announced its board authorized the repurchase of up to $1 billion of the company's common stock.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

April 30, 2025 07:12 ET (11:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10